nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS2—atherosclerosis	0.725	1	CbGaD
Nepafenac—PTGS2—leg—atherosclerosis	0.00662	0.145	CbGeAlD
Nepafenac—PTGS2—hindlimb—atherosclerosis	0.00591	0.13	CbGeAlD
Nepafenac—PTGS2—appendage—atherosclerosis	0.00507	0.111	CbGeAlD
Nepafenac—Endophthalmitis—Pravastatin—atherosclerosis	0.00433	0.0529	CcSEcCtD
Nepafenac—Pregnancy—Lovastatin—atherosclerosis	0.00429	0.0525	CcSEcCtD
Nepafenac—Pregnancy—Simvastatin—atherosclerosis	0.00402	0.0491	CcSEcCtD
Nepafenac—PTGS1—artery—atherosclerosis	0.00379	0.0831	CbGeAlD
Nepafenac—PTGS2—artery—atherosclerosis	0.00362	0.0794	CbGeAlD
Nepafenac—PTGS1—endothelium—atherosclerosis	0.0032	0.0702	CbGeAlD
Nepafenac—PTGS2—endothelium—atherosclerosis	0.00306	0.0671	CbGeAlD
Nepafenac—PTGS1—blood vessel—atherosclerosis	0.00295	0.0647	CbGeAlD
Nepafenac—Eye irritation—Lovastatin—atherosclerosis	0.00285	0.0349	CcSEcCtD
Nepafenac—PTGS2—blood vessel—atherosclerosis	0.00282	0.0618	CbGeAlD
Nepafenac—Cataract—Lovastatin—atherosclerosis	0.00256	0.0313	CcSEcCtD
Nepafenac—Diclofenac—PLA2G2A—atherosclerosis	0.00244	0.247	CrCbGaD
Nepafenac—Diabetes mellitus—Rosuvastatin—atherosclerosis	0.0024	0.0293	CcSEcCtD
Nepafenac—Cataract—Simvastatin—atherosclerosis	0.00239	0.0293	CcSEcCtD
Nepafenac—Cataract—Pravastatin—atherosclerosis	0.00216	0.0265	CcSEcCtD
Nepafenac—Diabetes mellitus—Simvastatin—atherosclerosis	0.0019	0.0232	CcSEcCtD
Nepafenac—Arthritis—Lovastatin—atherosclerosis	0.00182	0.0222	CcSEcCtD
Nepafenac—Arthritis—Ezetimibe—atherosclerosis	0.00179	0.0218	CcSEcCtD
Nepafenac—Diabetes mellitus—Niacin—atherosclerosis	0.00175	0.0213	CcSEcCtD
Nepafenac—Arthritis—Simvastatin—atherosclerosis	0.0017	0.0208	CcSEcCtD
Nepafenac—Arthritis—Niacin—atherosclerosis	0.00156	0.0191	CcSEcCtD
Nepafenac—Arthritis—Pravastatin—atherosclerosis	0.00154	0.0188	CcSEcCtD
Nepafenac—PTGS1—connective tissue—atherosclerosis	0.00151	0.0332	CbGeAlD
Nepafenac—Sinusitis—Rosuvastatin—atherosclerosis	0.00151	0.0184	CcSEcCtD
Nepafenac—PTGS2—connective tissue—atherosclerosis	0.00145	0.0317	CbGeAlD
Nepafenac—PTGS1—cardiovascular system—atherosclerosis	0.00132	0.0289	CbGeAlD
Nepafenac—Sinusitis—Lovastatin—atherosclerosis	0.00128	0.0156	CcSEcCtD
Nepafenac—PTGS2—cardiovascular system—atherosclerosis	0.00126	0.0276	CbGeAlD
Nepafenac—Sinusitis—Ezetimibe—atherosclerosis	0.00125	0.0153	CcSEcCtD
Nepafenac—Sinusitis—Simvastatin—atherosclerosis	0.0012	0.0146	CcSEcCtD
Nepafenac—PTGS1—adipose tissue—atherosclerosis	0.00116	0.0255	CbGeAlD
Nepafenac—PTGS2—adipose tissue—atherosclerosis	0.00111	0.0243	CbGeAlD
Nepafenac—Angiopathy—Ezetimibe—atherosclerosis	0.00109	0.0133	CcSEcCtD
Nepafenac—Immune system disorder—Ezetimibe—atherosclerosis	0.00108	0.0133	CcSEcCtD
Nepafenac—Sinusitis—Pravastatin—atherosclerosis	0.00108	0.0132	CcSEcCtD
Nepafenac—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00101	0.0123	CcSEcCtD
Nepafenac—Vision blurred—Lovastatin—atherosclerosis	0.001	0.0123	CcSEcCtD
Nepafenac—Eye disorder—Niacin—atherosclerosis	0.000982	0.012	CcSEcCtD
Nepafenac—Angiopathy—Niacin—atherosclerosis	0.000954	0.0117	CcSEcCtD
Nepafenac—Vision blurred—Simvastatin—atherosclerosis	0.000939	0.0115	CcSEcCtD
Nepafenac—Hypertension—Ezetimibe—atherosclerosis	0.000902	0.011	CcSEcCtD
Nepafenac—Dry mouth—Lovastatin—atherosclerosis	0.000887	0.0108	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000883	0.0108	CcSEcCtD
Nepafenac—Diclofenac—ALOX5—atherosclerosis	0.000876	0.0884	CrCbGaD
Nepafenac—Dry mouth—Ezetimibe—atherosclerosis	0.00087	0.0106	CcSEcCtD
Nepafenac—Vision blurred—Niacin—atherosclerosis	0.000862	0.0105	CcSEcCtD
Nepafenac—Vision blurred—Pravastatin—atherosclerosis	0.000849	0.0104	CcSEcCtD
Nepafenac—Nervous system disorder—Ezetimibe—atherosclerosis	0.000836	0.0102	CcSEcCtD
Nepafenac—Skin disorder—Ezetimibe—atherosclerosis	0.000828	0.0101	CcSEcCtD
Nepafenac—PTGS2—liver—atherosclerosis	0.000779	0.0171	CbGeAlD
Nepafenac—Hypertension—Pravastatin—atherosclerosis	0.000778	0.00951	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000774	0.00945	CcSEcCtD
Nepafenac—Dry mouth—Niacin—atherosclerosis	0.000762	0.00931	CcSEcCtD
Nepafenac—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000756	0.00924	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000736	0.009	CcSEcCtD
Nepafenac—Pruritus—Rosuvastatin—atherosclerosis	0.000726	0.00887	CcSEcCtD
Nepafenac—Skin disorder—Niacin—atherosclerosis	0.000725	0.00886	CcSEcCtD
Nepafenac—Diclofenac—CXCL8—atherosclerosis	0.000725	0.0732	CrCbGaD
Nepafenac—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000702	0.00858	CcSEcCtD
Nepafenac—Dizziness—Rosuvastatin—atherosclerosis	0.000678	0.00829	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Niacin—atherosclerosis	0.000645	0.00788	CcSEcCtD
Nepafenac—Headache—Rosuvastatin—atherosclerosis	0.000643	0.00785	CcSEcCtD
Nepafenac—Ketoprofen—CXCL8—atherosclerosis	0.000642	0.0648	CrCbGaD
Nepafenac—Hypersensitivity—Lovastatin—atherosclerosis	0.000641	0.00783	CcSEcCtD
Nepafenac—Hypersensitivity—Ezetimibe—atherosclerosis	0.000628	0.00768	CcSEcCtD
Nepafenac—Pruritus—Lovastatin—atherosclerosis	0.000615	0.00752	CcSEcCtD
Nepafenac—Nausea—Rosuvastatin—atherosclerosis	0.000609	0.00745	CcSEcCtD
Nepafenac—Pruritus—Ezetimibe—atherosclerosis	0.000603	0.00737	CcSEcCtD
Nepafenac—Hypersensitivity—Simvastatin—atherosclerosis	0.000599	0.00732	CcSEcCtD
Nepafenac—Ketorolac—PTGS2—atherosclerosis	0.000596	0.0602	CrCbGaD
Nepafenac—Pruritus—Simvastatin—atherosclerosis	0.000575	0.00703	CcSEcCtD
Nepafenac—Dizziness—Lovastatin—atherosclerosis	0.000575	0.00703	CcSEcCtD
Nepafenac—Bromfenac—PTGS2—atherosclerosis	0.000571	0.0577	CrCbGaD
Nepafenac—Dizziness—Ezetimibe—atherosclerosis	0.000564	0.00689	CcSEcCtD
Nepafenac—Vomiting—Lovastatin—atherosclerosis	0.000553	0.00676	CcSEcCtD
Nepafenac—Hypersensitivity—Niacin—atherosclerosis	0.00055	0.00672	CcSEcCtD
Nepafenac—Headache—Lovastatin—atherosclerosis	0.000545	0.00666	CcSEcCtD
Nepafenac—Vomiting—Ezetimibe—atherosclerosis	0.000542	0.00663	CcSEcCtD
Nepafenac—Hypersensitivity—Pravastatin—atherosclerosis	0.000542	0.00662	CcSEcCtD
Nepafenac—Dizziness—Simvastatin—atherosclerosis	0.000538	0.00657	CcSEcCtD
Nepafenac—Headache—Ezetimibe—atherosclerosis	0.000534	0.00653	CcSEcCtD
Nepafenac—Pruritus—Niacin—atherosclerosis	0.000528	0.00646	CcSEcCtD
Nepafenac—Pruritus—Pravastatin—atherosclerosis	0.00052	0.00636	CcSEcCtD
Nepafenac—Vomiting—Simvastatin—atherosclerosis	0.000517	0.00632	CcSEcCtD
Nepafenac—Nausea—Lovastatin—atherosclerosis	0.000516	0.00631	CcSEcCtD
Nepafenac—Headache—Simvastatin—atherosclerosis	0.000509	0.00623	CcSEcCtD
Nepafenac—Nausea—Ezetimibe—atherosclerosis	0.000507	0.00619	CcSEcCtD
Nepafenac—Dizziness—Niacin—atherosclerosis	0.000494	0.00603	CcSEcCtD
Nepafenac—Dizziness—Pravastatin—atherosclerosis	0.000486	0.00594	CcSEcCtD
Nepafenac—Tiaprofenic acid—PTGS2—atherosclerosis	0.000486	0.0491	CrCbGaD
Nepafenac—Nausea—Simvastatin—atherosclerosis	0.000483	0.0059	CcSEcCtD
Nepafenac—Vomiting—Niacin—atherosclerosis	0.000475	0.0058	CcSEcCtD
Nepafenac—Headache—Niacin—atherosclerosis	0.000468	0.00572	CcSEcCtD
Nepafenac—Vomiting—Pravastatin—atherosclerosis	0.000467	0.00571	CcSEcCtD
Nepafenac—Headache—Pravastatin—atherosclerosis	0.000461	0.00563	CcSEcCtD
Nepafenac—Magnesium salicylate—PTGS2—atherosclerosis	0.000452	0.0456	CrCbGaD
Nepafenac—Nausea—Niacin—atherosclerosis	0.000444	0.00542	CcSEcCtD
Nepafenac—Fenbufen—PTGS2—atherosclerosis	0.000442	0.0446	CrCbGaD
Nepafenac—Nausea—Pravastatin—atherosclerosis	0.000437	0.00534	CcSEcCtD
Nepafenac—Magnesium salicylate—ALB—atherosclerosis	0.000402	0.0406	CrCbGaD
Nepafenac—Salsalate—PTGS2—atherosclerosis	0.000384	0.0388	CrCbGaD
Nepafenac—Fenoprofen—PTGS2—atherosclerosis	0.000317	0.032	CrCbGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.000304	0.00221	CbGpPWpGaD
Nepafenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—atherosclerosis	0.000295	0.00215	CbGpPWpGaD
Nepafenac—Mefenamic acid—PTGS2—atherosclerosis	0.000294	0.0297	CrCbGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—INS—atherosclerosis	0.000292	0.00213	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—MTHFR—atherosclerosis	0.000292	0.00213	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000289	0.00211	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—CCL2—atherosclerosis	0.000288	0.0021	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—atherosclerosis	0.000284	0.00207	CbGpPWpGaD
Nepafenac—Fenoprofen—ALB—atherosclerosis	0.000283	0.0285	CrCbGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CRP—atherosclerosis	0.000278	0.00202	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	0.000272	0.00198	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—APOA1—atherosclerosis	0.000269	0.00196	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—SERPINE1—atherosclerosis	0.000269	0.00196	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—ALB—atherosclerosis	0.000268	0.00195	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—F2—atherosclerosis	0.000256	0.00187	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—ICAM1—atherosclerosis	0.000255	0.00186	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000251	0.00183	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000251	0.00183	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.00025	0.00182	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	0.000246	0.0018	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IFNG—atherosclerosis	0.000245	0.00178	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—GSTM1—atherosclerosis	0.000243	0.00177	CbGpPWpGaD
Nepafenac—Oxcarbazepine—ALB—atherosclerosis	0.000237	0.0239	CrCbGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000235	0.00171	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000235	0.00171	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—PTGS2—atherosclerosis	0.000235	0.00171	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—INS—atherosclerosis	0.000232	0.00169	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.00023	0.00168	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.00023	0.00168	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CCL2—atherosclerosis	0.000228	0.00166	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000226	0.00165	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL1B—atherosclerosis	0.000218	0.00159	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—LEP—atherosclerosis	0.000215	0.00157	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—SERPINE1—atherosclerosis	0.000213	0.00155	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—ALB—atherosclerosis	0.000213	0.00155	CbGpPWpGaD
Nepafenac—Diclofenac—PTGS2—atherosclerosis	0.000212	0.0214	CrCbGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	0.000211	0.00154	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TLR4—atherosclerosis	0.000211	0.00153	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000209	0.00152	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—NFKB1—atherosclerosis	0.000204	0.00148	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—ICAM1—atherosclerosis	0.000202	0.00147	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—NOS2—atherosclerosis	0.0002	0.00146	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000198	0.00144	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000198	0.00144	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000198	0.00144	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000198	0.00144	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000198	0.00144	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—atherosclerosis	0.000198	0.00144	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000196	0.00143	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IFNG—atherosclerosis	0.000194	0.00141	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000189	0.00138	CbGpPWpGaD
Nepafenac—Diclofenac—ALB—atherosclerosis	0.000188	0.019	CrCbGaD
Nepafenac—Ketoprofen—PTGS2—atherosclerosis	0.000187	0.0189	CrCbGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000186	0.00136	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000186	0.00136	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000185	0.00135	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000183	0.00133	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000181	0.00132	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CCL2—atherosclerosis	0.000181	0.00132	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.00018	0.00131	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000175	0.00127	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL1B—atherosclerosis	0.000173	0.00126	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LDLRAP1—atherosclerosis	0.000173	0.00126	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000169	0.00123	CbGpPWpGaD
Nepafenac—Ketoprofen—ALB—atherosclerosis	0.000167	0.0169	CrCbGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000166	0.00121	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000165	0.0012	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLTP—atherosclerosis	0.000162	0.00118	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—NFKB1—atherosclerosis	0.000162	0.00118	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—TNF—atherosclerosis	0.000158	0.00115	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000157	0.00115	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000157	0.00115	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000157	0.00115	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000157	0.00115	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000156	0.00113	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IFNG—atherosclerosis	0.000154	0.00112	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.00015	0.00109	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.00015	0.00109	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000149	0.00109	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000149	0.00108	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000145	0.00106	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000144	0.00105	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CXCL8—atherosclerosis	0.000143	0.00104	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ABCG8—atherosclerosis	0.000141	0.00102	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LTA4H—atherosclerosis	0.000141	0.00102	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.00014	0.00102	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000139	0.00101	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000139	0.00101	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL1B—atherosclerosis	0.000137	0.000998	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LDLRAP1—atherosclerosis	0.000137	0.000998	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000134	0.000975	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000131	0.000955	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MMP9—atherosclerosis	0.000129	0.000941	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLTP—atherosclerosis	0.000129	0.000938	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL6—atherosclerosis	0.000128	0.000931	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—TNF—atherosclerosis	0.000126	0.000916	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000121	0.00088	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000119	0.000869	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000119	0.000864	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000118	0.000859	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000117	0.000852	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000115	0.000839	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LTA4H—atherosclerosis	0.000112	0.000813	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ABCG8—atherosclerosis	0.000112	0.000813	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ABCG1—atherosclerosis	0.000111	0.00081	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.00011	0.000803	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MAPK3—atherosclerosis	0.00011	0.000799	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TGFB1—atherosclerosis	0.000106	0.000775	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—FABP4—atherosclerosis	0.000105	0.000762	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LCAT—atherosclerosis	0.000105	0.000762	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000104	0.000758	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOA4—atherosclerosis	0.000103	0.000748	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL6—atherosclerosis	0.000101	0.000739	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP7A1—atherosclerosis	0.000101	0.000734	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TNF—atherosclerosis	9.94e-05	0.000724	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOA4—atherosclerosis	9.73e-05	0.000709	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	9.61e-05	0.0007	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP27A1—atherosclerosis	9.32e-05	0.000679	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	9.28e-05	0.000676	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	9.18e-05	0.000668	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	8.95e-05	0.000652	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALOX15—atherosclerosis	8.84e-05	0.000643	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALOX5AP—atherosclerosis	8.84e-05	0.000643	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLA2G2A—atherosclerosis	8.84e-05	0.000643	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOA2—atherosclerosis	8.84e-05	0.000643	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ABCG1—atherosclerosis	8.83e-05	0.000643	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ABCG5—atherosclerosis	8.73e-05	0.000636	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	8.72e-05	0.000635	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	8.7e-05	0.000633	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	8.55e-05	0.000622	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LPA—atherosclerosis	8.43e-05	0.000614	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOA2—atherosclerosis	8.38e-05	0.00061	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LCAT—atherosclerosis	8.3e-05	0.000605	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—FABP4—atherosclerosis	8.3e-05	0.000605	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—BGN—atherosclerosis	8.16e-05	0.000595	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOA4—atherosclerosis	8.15e-05	0.000593	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	8.1e-05	0.00059	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOA5—atherosclerosis	8.08e-05	0.000589	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL6—atherosclerosis	8.02e-05	0.000584	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP7A1—atherosclerosis	8e-05	0.000583	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	7.89e-05	0.000575	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	7.85e-05	0.000572	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLA2G1B—atherosclerosis	7.78e-05	0.000567	CbGpPWpGaD
Nepafenac—PTGS2—Disease—BGN—atherosclerosis	7.74e-05	0.000564	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	7.69e-05	0.00056	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	7.63e-05	0.000556	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.62e-05	0.000555	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.6e-05	0.000554	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALOX5—atherosclerosis	7.51e-05	0.000547	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	7.47e-05	0.000544	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP27A1—atherosclerosis	7.4e-05	0.000539	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	7.28e-05	0.00053	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	7.24e-05	0.000527	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	7.11e-05	0.000518	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOA2—atherosclerosis	7.01e-05	0.000511	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALOX5AP—atherosclerosis	7.01e-05	0.000511	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLA2G2A—atherosclerosis	7.01e-05	0.000511	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALOX15—atherosclerosis	7.01e-05	0.000511	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.94e-05	0.000505	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ABCG5—atherosclerosis	6.93e-05	0.000505	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	6.92e-05	0.000504	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	6.76e-05	0.000493	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CST3—atherosclerosis	6.74e-05	0.000491	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NAMPT—atherosclerosis	6.74e-05	0.000491	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.7e-05	0.000488	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LIPC—atherosclerosis	6.7e-05	0.000488	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LPA—atherosclerosis	6.69e-05	0.000487	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOC3—atherosclerosis	6.65e-05	0.000485	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LDLR—atherosclerosis	6.61e-05	0.000482	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—BGN—atherosclerosis	6.48e-05	0.000472	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CETP—atherosclerosis	6.46e-05	0.00047	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.43e-05	0.000469	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOA5—atherosclerosis	6.42e-05	0.000467	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NAMPT—atherosclerosis	6.39e-05	0.000465	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOC3—atherosclerosis	6.31e-05	0.000459	CbGpPWpGaD
Nepafenac—PTGS2—Disease—LDLR—atherosclerosis	6.27e-05	0.000457	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.23e-05	0.000454	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SCARB1—atherosclerosis	6.19e-05	0.000451	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLA2G1B—atherosclerosis	6.18e-05	0.00045	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.11e-05	0.000445	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HSPA1B—atherosclerosis	6.06e-05	0.000441	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.05e-05	0.000441	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6.04e-05	0.00044	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.02e-05	0.000439	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALOX5—atherosclerosis	5.96e-05	0.000434	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NCF1—atherosclerosis	5.86e-05	0.000427	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HMGCR—atherosclerosis	5.84e-05	0.000425	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CYBA—atherosclerosis	5.51e-05	0.000402	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.51e-05	0.000401	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PARP1—atherosclerosis	5.4e-05	0.000393	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NAMPT—atherosclerosis	5.35e-05	0.00039	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.32e-05	0.000387	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LIPC—atherosclerosis	5.32e-05	0.000387	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOC3—atherosclerosis	5.28e-05	0.000385	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.27e-05	0.000384	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LDLR—atherosclerosis	5.25e-05	0.000382	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ABCA1—atherosclerosis	5.21e-05	0.000379	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CETP—atherosclerosis	5.13e-05	0.000373	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	5.04e-05	0.000367	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SCARB1—atherosclerosis	4.91e-05	0.000358	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.78e-05	0.000348	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HMGCR—atherosclerosis	4.64e-05	0.000338	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HMOX1—atherosclerosis	4.47e-05	0.000325	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOB—atherosclerosis	4.28e-05	0.000312	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTM1—atherosclerosis	4.16e-05	0.000303	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ABCA1—atherosclerosis	4.13e-05	0.000301	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LPL—atherosclerosis	4.09e-05	0.000298	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOB—atherosclerosis	4.06e-05	0.000295	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GPX1—atherosclerosis	3.99e-05	0.00029	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CD36—atherosclerosis	3.88e-05	0.000283	CbGpPWpGaD
Nepafenac—PTGS2—Disease—LPL—atherosclerosis	3.87e-05	0.000282	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PRKCG—atherosclerosis	3.77e-05	0.000274	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MTHFR—atherosclerosis	3.68e-05	0.000268	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARA—atherosclerosis	3.61e-05	0.000263	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HMOX1—atherosclerosis	3.55e-05	0.000258	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AGT—atherosclerosis	3.5e-05	0.000255	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MTHFR—atherosclerosis	3.49e-05	0.000254	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOE—atherosclerosis	3.43e-05	0.000249	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOB—atherosclerosis	3.4e-05	0.000247	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PDGFB—atherosclerosis	3.39e-05	0.000247	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CAV1—atherosclerosis	3.39e-05	0.000247	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOA1—atherosclerosis	3.39e-05	0.000247	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTM1—atherosclerosis	3.3e-05	0.000241	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOE—atherosclerosis	3.25e-05	0.000236	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LPL—atherosclerosis	3.24e-05	0.000236	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CAV1—atherosclerosis	3.22e-05	0.000234	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOA1—atherosclerosis	3.21e-05	0.000234	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GPX1—atherosclerosis	3.16e-05	0.00023	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CG—atherosclerosis	3.09e-05	0.000225	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CD36—atherosclerosis	3.08e-05	0.000224	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS2—atherosclerosis	3.03e-05	0.00022	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARG—atherosclerosis	2.98e-05	0.000217	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—INS—atherosclerosis	2.93e-05	0.000213	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MTHFR—atherosclerosis	2.92e-05	0.000213	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARA—atherosclerosis	2.87e-05	0.000209	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AGT—atherosclerosis	2.78e-05	0.000202	CbGpPWpGaD
Nepafenac—PTGS2—Disease—INS—atherosclerosis	2.77e-05	0.000202	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOE—atherosclerosis	2.72e-05	0.000198	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CAV1—atherosclerosis	2.69e-05	0.000196	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOA1—atherosclerosis	2.69e-05	0.000196	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALB—atherosclerosis	2.68e-05	0.000195	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NOS3—atherosclerosis	2.57e-05	0.000187	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SERPINE1—atherosclerosis	2.55e-05	0.000186	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CG—atherosclerosis	2.45e-05	0.000179	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS3—atherosclerosis	2.43e-05	0.000177	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARG—atherosclerosis	2.37e-05	0.000172	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGS2—atherosclerosis	2.35e-05	0.000171	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—INS—atherosclerosis	2.32e-05	0.000169	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALB—atherosclerosis	2.13e-05	0.000155	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NOS3—atherosclerosis	2.04e-05	0.000148	CbGpPWpGaD
Nepafenac—PTGS2—Disease—STAT3—atherosclerosis	1.74e-05	0.000126	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MAPK3—atherosclerosis	1.66e-05	0.000121	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TGFB1—atherosclerosis	1.61e-05	0.000117	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6—atherosclerosis	1.21e-05	8.83e-05	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AKT1—atherosclerosis	1.18e-05	8.59e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKT1—atherosclerosis	1.12e-05	8.14e-05	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AKT1—atherosclerosis	9.36e-06	6.82e-05	CbGpPWpGaD
